142 related articles for article (PubMed ID: 18073314)
1. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
Torlontano M; Durante C; Torrente I; Crocetti U; Augello G; Ronga G; Montesano T; Travascio L; Verrienti A; Bruno R; Santini S; D'Arcangelo P; Dallapiccola B; Filetti S; Trischitta V
J Clin Endocrinol Metab; 2008 Mar; 93(3):910-3. PubMed ID: 18073314
[TBL] [Abstract][Full Text] [Related]
2. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
[TBL] [Abstract][Full Text] [Related]
3. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
Luongo C; De Stefano MA; Ambrosio R; Volpe F; Porcelli T; Golia V; Bellevicine C; Troncone G; Masone S; Damiano V; Matano E; Klain M; Schlumberger M; Salvatore D
Thyroid; 2023 Mar; 33(3):294-300. PubMed ID: 36680751
[No Abstract] [Full Text] [Related]
4. The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study.
Butler PW; Smith SM; Linderman JD; Brychta RJ; Alberobello AT; Dubaz OM; Luzon JA; Skarulis MC; Cochran CS; Wesley RA; Pucino F; Celi FS
Thyroid; 2010 Dec; 20(12):1407-12. PubMed ID: 21054208
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
[TBL] [Abstract][Full Text] [Related]
6. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
[TBL] [Abstract][Full Text] [Related]
7. The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.
Hoftijzer HC; Heemstra KA; Visser TJ; le Cessie S; Peeters RP; Corssmit EP; Smit JW
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1527-33. PubMed ID: 21715540
[TBL] [Abstract][Full Text] [Related]
8. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
[TBL] [Abstract][Full Text] [Related]
9. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.
Escobar-Morreale HF; del Rey FE; Obregón MJ; de Escobar GM
Endocrinology; 1996 Jun; 137(6):2490-502. PubMed ID: 8641203
[TBL] [Abstract][Full Text] [Related]
10. Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine.
Escobar-Morreale HF; Obregón MJ; Hernandez A; Escobar del Rey F; Morreale de Escobar G
Endocrinology; 1997 Jun; 138(6):2559-68. PubMed ID: 9165049
[TBL] [Abstract][Full Text] [Related]
11. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.
Heemstra KA; Hoftijzer H; van der Deure WM; Peeters RP; Hamdy NA; Pereira A; Corssmit EP; Romijn JA; Visser TJ; Smit JW
J Bone Miner Res; 2010 Jun; 25(6):1385-91. PubMed ID: 20200941
[TBL] [Abstract][Full Text] [Related]
12. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
14. Determination of Frequency of Type 2 Deiodinase Thr92Ala Polymorphism (rs225014) in
Gawandi S; Jothivel K; Kulkarni S
Indian J Nucl Med; 2024; 39(1):24-28. PubMed ID: 38817730
[TBL] [Abstract][Full Text] [Related]
15. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.
Canani LH; Capp C; Dora JM; Meyer EL; Wagner MS; Harney JW; Larsen PR; Gross JL; Bianco AC; Maia AL
J Clin Endocrinol Metab; 2005 Jun; 90(6):3472-8. PubMed ID: 15797963
[TBL] [Abstract][Full Text] [Related]
16. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.
Escobar-Morreale HF; Obregón MJ; Escobar del Rey F; Morreale de Escobar G
J Clin Invest; 1995 Dec; 96(6):2828-38. PubMed ID: 8675653
[TBL] [Abstract][Full Text] [Related]
17. Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
Santoro AB; Vargens DD; Barros Filho Mde C; Bulzico DA; Kowalski LP; Meirelles RM; Paula DP; Neves RR; Pessoa CN; Struchine CJ; Suarez-Kurtz G
Br J Clin Pharmacol; 2014 Nov; 78(5):1067-75. PubMed ID: 24910925
[TBL] [Abstract][Full Text] [Related]
18. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
Werneck de Castro JP; Fonseca TL; Ueta CB; McAninch EA; Abdalla S; Wittmann G; Lechan RM; Gereben B; Bianco AC
J Clin Invest; 2015 Feb; 125(2):769-81. PubMed ID: 25555216
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine replacement therapy after thyroid surgery.
Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
[TBL] [Abstract][Full Text] [Related]
20. Serum thyrotropin concentrations are more highly correlated with serum triiodothyronine concentrations than with serum thyroxine concentrations in thyroid hormone-infused thyroidectomized rats.
Emerson CH; Lew R; Braverman LE; DeVito WJ
Endocrinology; 1989 May; 124(5):2415-8. PubMed ID: 2707159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
